Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01430351
Title Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

glioblastoma

gliosarcoma

Therapies

Metformin + Temozolomide

Mefloquine + Temozolomide

Memantine + Metformin + Temozolomide

Mefloquine + Memantine + Temozolomide

Mefloquine + Memantine + Metformin + Temozolomide

Temozolomide

Mefloquine + Metformin + Temozolomide

Memantine + Temozolomide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.